English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Conferences
Conferences
Sign up for latest coverage
Submit your event
Conferences
e
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Search conferences
Category
All
Disease Areas
Patient Care
Policy
Prevention & screening
Treatments
Sub-category
All
Region
All
Asia
Middle East and North Africa
Europe
North America
Central America and the Caribbean
South America
Africa
Australia and Oceania
Antarctica
Country
All
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Keyword
Share :
ESMO 2012
28 Sep - 2 Oct 2012
Videos
News
Advice to young oncologists
Prof Jose Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
15 Feb 2013
Evolving patient management in metastatic and non-metastatic castration...
Professor Noel Clarke, Dr Heather Payne, Prof Karim Fizazi,Prof John...
12 Nov 2012
Advances in advanced renal cell carcinoma from ESMO 2012: Part 1
Prof Tim Eisen - Addenbrooke's Oncology Centre, UK, Prof Bernard Escudier...
15 Oct 2012
Advances in advanced renal cell carcinoma from ESMO 2012: Part 3
Prof Tim Eisen - Addenbrooke's Oncology Centre, Cambridge, Prof Bernard...
13 Oct 2012
Advances in advanced renal cell carcinoma from ESMO 2012: Part 2
Prof Tim Eisen - Addenbrooke's Oncology Centre, Cambridge, Prof Bernard...
13 Oct 2012
Advances in advanced metastatic renal cell carcinoma from ESMO 2012
Dr Robert Motzer - The Memorial Sloan-Kettering Cancer Center, USA
12 Oct 2012
Treating platinum resistant ovarian cancer
Dr Andres Poveda – Fundacion Instituto Valenciano de Oncologia, Spain
12 Oct 2012
Developing technologies for personalised treatment
Dr Atanasio Pandiella – Instituto de Biologia Molecular y Celular del Cancer...
12 Oct 2012
Nab-paclitaxel and gemcitabine combating pancreatic cancer
Dr Michel Ducreux – Institut Gustave Roussy, Paris, France
12 Oct 2012
Chemotherapy and radiotherapy in advanced local non-small cell lung cancer
Dr Dirk De Ruysscher – University of Leuven, Netherlands
12 Oct 2012
Hepatic chemosaturation therapy
Dr Krishna Kandarpa – Delcath Systems Inc, Dr Pier Ferrucci – European Insitute...
11 Oct 2012
Advances in soft tissue sarcoma from ESMO 2012
Prof Jean Yves Blay - Université Claude Bernard, France
11 Oct 2012
Genes, chromosomes and the treatment of bladder cancer
Dr Jonathan Rosenburg - Memorial Sloan Kettering Cancer Center, New York, USA
10 Oct 2012
Analysing the efficacy of treatment through Response Evaluation Criteria in...
Dr Yves Menu – Saint Antoine Hospital, Paris, France
9 Oct 2012
Surgical challenges to retroperitoneal sarcomas
Dr Angelo Dei Tos – Department of Oncology, General Hospital of Treviso, Italy
9 Oct 2012
Treatment approaches for desmoid tumours
Dr Sylvie Bonvalot – Institut Gustave Roussy, Paris, France
9 Oct 2012
Development and expansion of the IFOM-IEO campus
Prof Marco Foiani – University of Milan, Italy and Scientific Director IFOM
9 Oct 2012
Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype
Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal
9 Oct 2012
Clinical trials and drug developments in pancreatic cancer
Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy
9 Oct 2012
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast...
Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy
9 Oct 2012
Advances in advanced prostate cancer from ESMO 2012; focus on abiraterone...
Dr Chris Parker , Dr Charles Ryan, Prof Karim Fizazi
9 Oct 2012
Histology and non-histology driven therapy for soft tissue sarcomas and the...
Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy
9 Oct 2012
MET inhibitors for non-small cell lung cancer
Prof Georgio Scagliotti – University of Torino, Italy
9 Oct 2012
Multidisciplinary benefits to radiotherapy
Prof Vincenzo Valentini – President of ESTRO
9 Oct 2012
Pathology and development of ovarian cancer
Dr Jamie Prat – Hospital De La Santa Creu I San Pau, Spain
9 Oct 2012
Putting the theory of personalised medicine into practice
Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert...
8 Oct 2012
Treatment of ALK+ lung cancer with crizotinib, Profile 1007
Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
8 Oct 2012
The first phase II trial for the management of oesophageal cancer
Prof David Ferry – New Cross Hospital, Wolverhampton, UK
8 Oct 2012
Phase III MISSION trial: Sorafenib does not extend overall survival as third or...
Dr Tony Mok – The Chinese University of Hong Kong
8 Oct 2012
Trametinib and dabrafenib combination therapy against metastatic melanoma
Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia
8 Oct 2012
New developments in molecular imaging
Prof Wim Oyen – Radboud University Nijmagen Medical Centre, Netherlands
5 Oct 2012
Personalised cancer medicine and research: Today’s best practice
Prof José Baselga - Massachusetts General Hospital, Boston, USA
5 Oct 2012
Treating liver metastases in colorectal cancer
Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany
4 Oct 2012
Putting drugs to work against brain metastases in HER2 positive breast cancer:...
Dr Thomas Bachelot – Centre Leon Berard, Lyon
4 Oct 2012
The Multinational Association of Supportive Care in Cancer (MASCC)
Dr Stephen Grunberg – University of Vermont, Burlington, USA
4 Oct 2012
Defining personalised medicine and patient empowerment
Prof Gabriella Pravettoni – University of Milan, Italy
4 Oct 2012
Phase I study examining PI 3 kinase inhibitor for various tumours
Dr Pamela Munster – University of California, San Francisco, USA
4 Oct 2012
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK...
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
30 Sep 2012
A proof-of-concept study of ODM-201 in patients with progressive castration...
Dr Christophe Massard - Institute Gustave Roussy, Paris, France
30 Sep 2012
Too few women being offered breast-conserving treatment?
Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy
30 Sep 2012
Personalised medicine: Hype or hope?
Jola Gore Booth - Europacolon
30 Sep 2012
Awareness of personalised medicine in cancer patients
Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium
30 Sep 2012
BRAF inhibitor dabrafenib alone vs combination with MEK1/2 inhibitor trametinib...
Dr Georgina Long - Melanoma Institute Australia, Sydney, Australia
29 Sep 2012
Phase I and II trials focus on drug combination slowing development of...
Prof Yossef Yarden - Weizmann Institute of Science, Israel.
29 Sep 2012
Gefitinib versus placebo in oesophageal cancer progressing after chemotherapy
Prof David Ferry - New Cross Hospital, Wolverhampton, UK
29 Sep 2012
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib
Dr Tony Mok - Chinese University of Hong Kong
29 Sep 2012
Sorafenib does not extend overall survival as third or fourth line therapy in...
Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain
29 Sep 2012
More from
e
cancer